MediciNova, Inc. revenue breakdown overview

MediciNova, Inc. revenue for the last year amounted to 1.00 M USD, the most of which — 1.00 M USD — came from its highest performing source at the moment, Small Molecule Therapeutics, the year earlier bringing 4.04 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought MediciNova, Inc. 1.00 M USD, and the year before that — 4.04 M USD.